DFAT is now welcoming proposals for global health Product Development and Access Partnerships. The availability of novel drugs, vaccines, diagnostics and vector control tools is critical for the fight against a range of high-burden infectious diseases, including drug-resistant strains.
Over the past 20 years, a number of global Product Development Partnerships (PDPs) have been established to foster the development of new global health products. PDPs work with research institutions, pharmaceutical companies and other actors to build a broad pipeline of priority products and take them through pre-clinical and clinical trials. PDPs have been successful in stewarding many products through to market authorisation. Access to new medical products for countries in our region relies not only on a well-funded research and development pipeline, but also requires safe and effective product introduction pathways, including rigorous regulatory assessment and affordable pricing. PDPs work closely with allied organisations to maximise the uptake of products emerging from their pipeline.
DFAT is calling for proposals from PDPs and allied organisations, focusing on products targeting infectious diseases of particular concern to the Pacific and Southeast Asia. This includes, for example, malaria, tuberculosis, dengue, sexually transmitted diseases (including HIV and HPV) and neglected tropical diseases such as scabies and trachoma. Proposals that address barriers to product access and utilisation in the Pacific and Southeast Asia, through engagement between product development partners and other institutions, are encouraged.
Detailed information on DFAT requirements, assessment process, key dates and guidance to support applications can be found in Key Documents below. Please ensure you read all documents before drafting your proposal. We encourage all applicants to monitor this webpage regularly, including monitoring additions to frequently asked questions (FAQs). The information session (held on 1 March 2023) recording and transcripts have now been uploaded and are accessible below.
Please note that some issues in the information session have been clarified in the Frequently Asked Questions. Updated Guidelines were also reissued on 16 March 2023 to accommodate a revised program logic. Please regularly check this website for the latest advice and updates before submitting applications.
Key Dates for Product Development and Access Partnerships Call for Proposals
|Call for proposals open||23 February 2023|
|Registration deadline to attend Applicant Briefings||28 February 2023 6pm AEDT|
|Applicant Briefing||Virtual briefing: 1 March 2023, 9am AEDT|
|Prospective applicants allowed to submit open questions||13 March 2023, 6pm AEDT|
|DFAT answers to open questions published along with questions||22 March 2023, 6pm AEDT|
|Proposal submission deadline||20 April 2023, 6pm AEST|
Key Documents for Product Development and Access Partnerships Call for Proposals
Product Development and Access Partnership Information Session 1 March 2023
Following the session, you are now able to view the video of the session below.
Information Session Transcripts and Frequently Asked Questions
If you require alternative accessible versions of any of the documentation or wish to submit a question, please email the Indo-Pacific Centre for Health Security.